(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on the statements in Valeant's annual report filed today.

Boeing Beats on Cash Flow, Books New Charge on Air Force One
21:43

Nvidia’s $750 Billion in Deals Reignite Circular AI Fears
16:56

Special Edition: Nvidia CEO Jensen Huang on Investing in South Korea
14:41